Sec. 1825. ### (a)
342 words·~2 min read·
/statute-compilations/comps-9551/sec-1825A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 1825 ###
(a)Notwithstanding section 1101, the level for “Department of Health and Human Services, Office of the Secretary, Public Health and Social Services Emergency Fund” shall be $676,180,000, of which $65,578,000 shall be for expenses necessary to prepare for and respond to an influenza pandemic, none of which shall be available past September 30, 2011, and $35,000,000, to remain available until expended, shall be for expenses necessary for fit-out and other costs related to a competitive lease procurement to renovate or replace the existing headquarters building for Public Health Service agencies and other components of the Department of Health and Human Services: *Provided,* That in addition, $415,000,000 of the funds transferred to the account under the heading “Department of Health and Human Services, Office of the Secretary, Public Health and Social Services Emergency Fund” in Public Law 111-117 under the fourth paragraph under such heading may be used to support advanced research and development pursuant to section 319L of the PHS Act and other administrative expenses of the Biomedical Advanced Research and Development Authority: *Provided further,* That the first proviso in the first paragraph under such heading in division D of Public Law 111-117 and the language in such paragraph designating $10,000,000 to support delivery of medical countermeasures shall not apply to funds provided in this section: *Provided further,* That the fourth paragraph under such heading shall not apply to funds appropriated by this division. ###
(b)Of the amounts provided under the heading “Department of Health and Human Services, Office of the Secretary, Public Health and Social Services Emergency Fund” in Public Laws 111-8 and 111-117 and available for expenses necessary to prepare for and respond to an influenza pandemic, $170,000,000 may also be used— ####
(1)to plan, conduct, and support research to advance regulatory science to improve the ability to determine safety, effectiveness, quality, and performance of medical countermeasure products against chemical, biological, radiological, and nuclear agents including influenza virus; and ####
(2)to analyze, conduct, and improve regulatory review and compliance processes for such products.
Connections1 off-index
1 reference not yet in our index
- Pub. L. 111-117
Citation graph
cites case law
Sec. 1825
### (a)
Pub. L.Pub. L. 111-117
Cites 1Cited by 0 across 0 sources